Axceler8 Rx: AI Precision for Clinical Trial Acceleration
A next-generation analytics platform built by Arthur D. Little & Vega IT, delivering measurable speed, accuracy, and control across clinical development.
Already used by leading pharma study teams to accelerate feasibility, startup, and enrollment.
Voices from the frontlines of clinical trials
Strong work. I’m truly impressed by the collaboration and input from so many contributors to bring this together. Reviewing the results put a huge smile on my face this morning!
Thank you for this view that places all scenarios into one simple, easy-to-digest view. This will be extremely helpful for upcoming strategic discussions with senior leadership to determine the optimal study footprint and understand tradeoffs.
The additional site selection list helped us mitigate the high volume of declines during SFQ with our original list, as we pushed toward adding ~100 more sites.
Many thanks for the efficient turnaround with these targeted analyses. The message was clear — even with a 30% faster activation rate, overall last-patient-in barely moves. That clarity has helped our leadership focus on the right levers.”
Very useful information on the deep-dive rationale for site and country-specific rating in Portugal, as we consider additional high-potential countries in Europe. Thank you very much.
Thank you for the close collaboration over the past weeks to deliver semi-bottom-up projections for the critical lymphoma study.
Quantified, Proven Acceleration
End-to-end Unified Acceleration Intelligence
Axceler8 Rx uses real-world trial data, AI analytics, and operational expertise from Arthur D. Little in a connected command center developed by Vega IT for clinical trial acceleration.
It replaces static spreadsheets and fragmented trackers with predictive tools that show, in real time, how to reach milestones faster.
Platform overview
Planning
Country & Site Selector
Identify high-performing sites by combining investigator experience, regional epidemiology, competition, and cost. Natural-language search expands the universe of indication-specific sites and scores them for likelihood of success.
Semi-Bottom-Up Enrollment Simulator
Model realistic enrollment timelines before first-patient-in. Toggle site activation delays, screen-failure rates, or startup assumptions and instantly visualize impact. Used by study teams to test site footprint & acceleration strategies in real time.
Recruitment tools
Program & Study Dashboards
Centralize live study intelligence across countries and sites.Understand where activation or enrollment is ahead of or behind plan — and how to strategize activity to achieve corporate targets.
Site activation dashboard
Pinpoint activation bottlenecks with task-level precision using task dependency graphing. The Site Navigator module’s AI-driven forecasts demonstrated 81% accuracy in predicting activation milestones across a global portfolio.
Site performance dashboard
Identify the sites driving enrollment — and those lagging. Integrate historical communication and engagement data to tailor actions to support underperforming sites and motivate high-performing sites to go further.
Participant dashboard
Track screening, screen-failure, and enrollment patterns by site and country. Quickly distinguish global vs. local causes to guide training, site resource support, or protocol refinement.
Country dashboard
Compare performance across geographies. Gain foresight into what it takes to achieve monthly enrollment and activation targets, understanding which countries must be supported and mitigated now to stay on schedule.
Acceleration deliverable dashboard
Monitor the most critical enrollment-driving initiatives, owners, and progress in one view. Highlight delays early and maintain cross-functional alignment.
Site Communication Dashboard
Unify site-facing communication across roles — medical, clinical, regional, and CRO — with historical visibility to guide the next touchpoint.
Competitive Dashboard
Visualize competitive trial overlap and its impact on site performance. Adjust engagement and targeting strategies to maintain an edge.
DataSpeak
Identify high-performing sites by combining investigator experience, regional epidemiology, competition, and cost.
Natural-language search expands the universe of indication-specific sites and scores them for likelihood of success.
About the team
Axceler8 Rx is developed and delivered by Arthur D. Little, the world’s first management consultancy and a recognized leader in clinical-trial acceleration together with Vega IT - a digital product development and system integration company with global experience in delivering innovative digital solutions in the healthcare industry in more than 25 countries.
Our team includes clinical operations veterans, data scientists, and AI engineers who have delivered measurable acceleration across oncology, neurology, immunology, cardiology, and rare disease studies.
Bring Predictive Intelligence to Your Next Study
Discover how Axceler8 Rx can transform feasibility, forecasting, and execution with proven analytics and expert support.
